Skip to Main Content

Paper Details

Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Oncologist
65
2015
ERBB2, ERBB2 mutations, HER2, breast, gastric, and esophageal cancers, breast, gastric, and gastroesophageal cancers, patients, solid tumor, tumor, tumor types, tumors
Author NameAffiliation
Jeffrey S RossFoundation Medicine, Albany Medical College
Siraj M AliFoundation Medicine, Albany Medical College
Vincent A MillerFoundation Medicine, Albany Medical College
Roman YelenskyFoundation Medicine, Albany Medical College
  • 1 - 4

Datasets

Release 1.2